NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Institute of Medicine (US) Committee to Study Medication Development and Research at the National Institute on Drug Abuse; Fulco CE, Liverman CT, Earley LE, editors. Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector. Washington (DC): National Academies Press (US); 1995.
Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector.
Show detailsInstitute of Medicine
Committee to Study Medication Development and Research at the National Institute on Drug Abuse
Workshop on Policies to Stimulate Private Sector Development of Anti-Addiction Medications
June 13, 1994
Lecture Room, National Academy of Sciences
2101 Constitution Avenue, N.W. Washington, D.C.
Workshop Agenda
| 8:00–8:30 a.m. | BREAKFAST |
| 8:30–8:45 | OPENING REMARKS |
| Laurence E. Earley, Chairman | |
| 8:45–10:45 | Panel I: Private Sector Obstacles and Opportunities |
| Moderator: J. Richard Crout | |
| Panel: Dee Gillespie, Steve Grossman, Richard Merrill, Sherri Samotin * | |
| 10:45–12:30 | Panel II: Regulatory Issues |
| Moderator: Herbert Kleber | |
| Panel: Robert Angarola, John Coleman, George DeVaux * , Nicholas Reuter, Frank Vocci | |
| 12:30–1:15 | LUNCH |
| 1:15–2:30 | Panel III: Research and Training Issues |
| Moderator: Kathleen Foley | |
| Panel: John Ambre, Ann Geller, Charles Grudzinskas, David Lewis* | |
| 2:30–4:00 | Panel IV: Treatment Financing Issues |
| Moderator: Peter Carpenter | |
| Panel: John Caulkins*, Jack Durell*, Eric Goplerud | |
| 4:00–5:00 | Plenary Session |
| 5:00 | Adjourn |
- *
Presenters
Participant List
John Ambre
American Medical Association
Robert Angarola
Hyman, Phelps and McNamara
Gary Bennett
National Institute of Dental Research
Ann Carter
Drug Enforcement
Administration
John Caulkins
RAND
John Coleman
Drug Enforcement
Administration
Leonard Cook
National Institute on Drug Abuse
James Cooper
National Institute on Drug Abuse
Paul Coulis
National Institute on Drug Abuse
Miriam Davis
Health Policy Consultant
George DeVaux
BioDevelopment Corporation
Chris Doherty
Fox, Bennett and Turner
Jack Durell
Treatment Research Institute
Joel Egertson
National Institute on Drug Abuse
John Engel
Fox, Bennett and Turner
Susan Everingham
RAND
Lorraine Fishback
Department of Health and
Human Services
Gretchen Freshneur
Drug Enforcement
Administration
Jim Friedman
Substance Abuse and Mental
Health Services Administration
Ann Geller
American Society of Addiction
Medicine
Dee Gillespie
DuPont-Merck
Steve Grossman
Hill and Knowlton
Charles Grudzinskas
National Institute on Drug Abuse
Anthony Guarino
University of South Alabama
Thomas Heffner
Parke-Davis Pharmaceutical
Research
James Isbister
Pharmavene, Inc.
Jerome Jeffe
Substance Abuse and Mental
Health Services Administration
Betty Jones
Food and Drug Administration
Thomas Kuchenberg
Food and Drug Administration
Irwin Lerner
Hoffman-LaRoche
David Lewis
Brown University
Barbara McGarey
National Institutes of Health
Richard Merrill
University of Virginia
School of Law
Jacques Normand
National Research Council
Marcy Oppenheimer
Department of Health and
Human Services
Richard Rettig
Institute of Medicine
Nicholas Reuter
Food and Drug Administration
Barbara Roberts
Office of National Drug
Control Policy
Sherri Samotin
Wilkerson Group, Inc.
Frank Sapienza
Drug Enforcement
Administration
Robert Talbot-Stern
Legal Consultant
John Thomas
BioDevelopment Corporation
Frank Vocci
National Institute on Drug Abuse
Bonnie Wilford
George Washington University
Curtis Wright
Food and Drug Administration
Thomas Wyatt
National Association of
State Controlled Substance
Authorities
- Workshop Agenda and Participants - Development of Medications for the Treatment ...Workshop Agenda and Participants - Development of Medications for the Treatment of Opiate and Cocaine Addictions
Your browsing activity is empty.
Activity recording is turned off.
See more...